Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
David K. Janik, PhD
Principal Scientist
Novartis Pharmaceuticals Corp
Poster(s):
162: Pharmacokinetics of DYP688 in Patients With Metastatic Uveal Melanoma & Other GNAQ/11 Mutant Melanomas
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET